Overall Technical outlook

Price Summary

Torrent Pharmaceuticals Limited's stock opened at 3621.3 on 2025-08-14, surged to 3647.7, hit a low of 3593.9, and closed up 0.05% at 3623.0, with 382403 shares traded.
Over the past year, the stock's highest price was 3768.1, and its lowest was 2930.3.
The future price of TORNTPHARM is anticipated to range from 3425.0 to 4380.0, with an expected mean price of 3937.0386, according to the recommendations of 26 analysts.

Technicals

Support and Resistance: The current price sits at 3623.0, supported at 3504.6 and capped by resistance at 3730.6. These levels define a range for TORNTPHARM where the price might stabilize, with 3504.6 as a floor and 3730.6 as a ceiling.
TORNTPHARM supportResistance 604dfe
Support/Resistance for TORNTPHARM


Aroon: The AROON is currently in a neutral position for Torrent Pharmaceuticals Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
TORNTPHARM aroon 604dfe
Aroon chart for Torrent Pharmaceuticals Limited


Bol. Bands: The current state of the BOLL BANDS is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
TORNTPHARM bbands 604dfe
Bolinger Bands chart for Torrent Pharmaceuticals Limited


Parabolic SAR: The PSAR remains bearish for Torrent Pharmaceuticals Limited, establishing a crucial resistance level that could hinder any bullish attempts. This ongoing bearish outlook suggests that the market may continue to face resistance, making it difficult for prices to rise.
TORNTPHARM psar 604dfe
Parabolic Stop and Reverse chart for Torrent Pharmaceuticals Limited


Stochastic: The STOCHASTIC is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
TORNTPHARM stoch 604dfe
Stochastic chart for Torrent Pharmaceuticals Limited


Tripple Moving Agerage: The alignment of the 20, 50, and 100 moving averages indicates a bearish trend for TORNTPHARM, but the wavering slopes of the 20 and 50 SMAs suggest that this momentum may be fading. This weakening could be a precursor to a bullish reversal, as the market's current downtrend shows signs of losing steam. Investors may soon see a shift towards more positive price action as the trend begins to change.
TORNTPHARM trippleSMA 604dfe
Tripple SMA chart for Torrent Pharmaceuticals Limited


A thorough analysis of a company involves looking at both its fundamentals and technical data. The fundamentals, including revenue, profitability, and management quality, offer insight into the company's long-term value. Additionally, understanding the broader industry context, such as market competition and regulatory challenges, helps to better interpret the company's stock performance. By combining both fundamental and technical analysis, you can derive more meaningful inferences about the company's future prospects.